Literature DB >> 11884534

Novel swine virulence determinant in the left variable region of the African swine fever virus genome.

J G Neilan1, L Zsak, Z Lu, G F Kutish, C L Afonso, D L Rock.   

Abstract

Previously we have shown that the African swine fever virus (ASFV) NL gene deletion mutant E70DeltaNL is attenuated in pigs. Our recent observations that NL gene deletion mutants of two additional pathogenic ASFV isolates, Malawi Lil-20/1 and Pr4, remained highly virulent in swine (100% mortality) suggested that these isolates encoded an additional virulence determinant(s) that was absent from E70. To map this putative virulence determinant, in vivo marker rescue experiments were performed by inoculating swine with infection-transfection lysates containing E70 NL deletion mutant virus (E70DeltaNL) and cosmid DNA clones from the Malawi NL gene deletion mutant (MalDeltaNL). A cosmid clone representing the left-hand 38-kb region (map units 0.05 to 0.26) of the MalDeltaNL genome was capable of restoring full virulence to E70DeltaNL. Southern blot analysis of recovered virulent viruses confirmed that they were recombinant E70DeltaNL genomes containing a 23- to 28-kb DNA fragment of the Malawi genome. These recombinants exhibited an unaltered MalDeltaNL disease and virulence phenotype when inoculated into swine. Additional in vivo marker rescue experiments identified a 20-kb fragment, encoding members of multigene families (MGF) 360 and 530, as being capable of fully restoring virulence to E70DeltaNL. Comparative nucleotide sequence analysis of the left variable region of the E70DeltaNL and Malawi Lil-20/1 genomes identified an 8-kb deletion in the E70DeltaNL isolate which resulted in the deletion and/or truncation of three MGF 360 genes and four MGF 530 genes. A recombinant MalDeltaNL deletion mutant lacking three members of each MGF gene family was constructed and evaluated for virulence in swine. The mutant virus replicated normally in macrophage cell culture but was avirulent in swine. Together, these results indicate that a region within the left variable region of the ASFV genome containing the MGF 360 and 530 genes represents a previously unrecognized virulence determinant for domestic swine.

Entities:  

Mesh:

Year:  2002        PMID: 11884534      PMCID: PMC136047          DOI: 10.1128/jvi.76.7.3095-3104.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses.

Authors:  T G Senkevich; E V Koonin; J J Bugert; G Darai; B Moss
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

2.  An African swine fever virus Bc1-2 homolog, 5-HL, suppresses apoptotic cell death.

Authors:  C L Afonso; J G Neilan; G F Kutish; D L Rock
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 3.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

4.  A BIR motif containing gene of African swine fever virus, 4CL, is nonessential for growth in vitro and viral virulence.

Authors:  J G Neilan; Z Lu; G F Kutish; L Zsak; T G Burrage; M V Borca; C Carrillo; D L Rock
Journal:  Virology       Date:  1997-04-14       Impact factor: 3.616

5.  An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene.

Authors:  L Zsak; Z Lu; G F Kutish; J G Neilan; D L Rock
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death.

Authors:  A Brun; C Rivas; M Esteban; J M Escribano; C Alonso
Journal:  Virology       Date:  1996-11-01       Impact factor: 3.616

7.  Inhibition of apoptosis by the African swine fever virus Bcl-2 homologue: role of the BH1 domain.

Authors:  Y Revilla; A Cebrián; E Baixerás; C Martínez; E Viñuela; M L Salas
Journal:  Virology       Date:  1997-02-17       Impact factor: 3.616

8.  Two novel multigene families, 530 and 300, in the terminal variable regions of African swine fever virus genome.

Authors:  T Yozawa; G F Kutish; C L Afonso; Z Lu; D L Rock
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

9.  Long-term persistent infection of swine monocytes/macrophages with African swine fever virus.

Authors:  C Carrillo; M V Borca; C L Afonso; D V Onisk; D L Rock
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

10.  Potential virulence determinants in terminal regions of variola smallpox virus genome.

Authors:  R F Massung; J J Esposito; L I Liu; J Qi; T R Utterback; J C Knight; L Aubin; T E Yuran; J M Parsons; V N Loparev
Journal:  Nature       Date:  1993 Dec 23-30       Impact factor: 49.962

View more
  31 in total

1.  African Swine Fever Virus Georgia Isolate Harboring Deletions of MGF360 and MGF505 Genes Is Attenuated in Swine and Confers Protection against Challenge with Virulent Parental Virus.

Authors:  Vivian O'Donnell; Lauren G Holinka; Douglas P Gladue; Brenton Sanford; Peter W Krug; Xiqiang Lu; Jonathan Arzt; Bo Reese; Consuelo Carrillo; Guillermo R Risatti; Manuel V Borca
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

2.  The progressive adaptation of a georgian isolate of African swine fever virus to vero cells leads to a gradual attenuation of virulence in swine corresponding to major modifications of the viral genome.

Authors:  Peter W Krug; Lauren G Holinka; Vivian O'Donnell; Bo Reese; Brenton Sanford; Ignacio Fernandez-Sainz; Douglas P Gladue; Jonathan Arzt; Luis Rodriguez; Guillermo R Risatti; Manuel V Borca
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

3.  Inhibition of a large double-stranded DNA virus by MxA protein.

Authors:  Christopher L Netherton; Jennifer Simpson; Otto Haller; Thomas E Wileman; Haru-Hisa Takamatsu; Paul Monaghan; Geraldine Taylor
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

4.  Expression library immunization can confer protection against lethal challenge with African swine fever virus.

Authors:  Anna Lacasta; María Ballester; Paula L Monteagudo; Javier M Rodríguez; María L Salas; Francesc Accensi; Sonia Pina-Pedrero; Albert Bensaid; Jordi Argilaguet; Sergio López-Soria; Evelyne Hutet; Marie Frédérique Le Potier; Fernando Rodríguez
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

5.  The subcellular distribution of multigene family 110 proteins of African swine fever virus is determined by differences in C-terminal KDEL endoplasmic reticulum retention motifs.

Authors:  Christopher Netherton; Isabelle Rouiller; Thomas Wileman
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  African swine fever virus multigene family 360 genes affect virus replication and generalization of infection in Ornithodoros porcinus ticks.

Authors:  T G Burrage; Z Lu; J G Neilan; D L Rock; L Zsak
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  African swine fever virus multigene family 360 and 530 genes affect host interferon response.

Authors:  C L Afonso; M E Piccone; K M Zaffuto; J Neilan; G F Kutish; Z Lu; C A Balinsky; T R Gibb; T J Bean; L Zsak; D L Rock
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 8.  Open reading frame 3 protein of hepatitis E virus: Multi-function protein with endless potential.

Authors:  Yong-Lin Yang; Yu-Chen Nan
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

9.  Thoughts on African Swine Fever Vaccines.

Authors:  Daniel L Rock
Journal:  Viruses       Date:  2021-05-20       Impact factor: 5.048

10.  DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies.

Authors:  Jordi M Argilaguet; Eva Pérez-Martín; Miquel Nofrarías; Carmina Gallardo; Francesc Accensi; Anna Lacasta; Mercedes Mora; Maria Ballester; Ivan Galindo-Cardiel; Sergio López-Soria; José M Escribano; Pedro A Reche; Fernando Rodríguez
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.